JCIC Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.54M | Sell |
36,521
-686
| -2% | -$47.6K | 1.06% | 32 |
|
|
2024
Q4 | $3.2M | Buy |
37,207
+665
| +2% | +$57.2K | 1.3% | 26 |
|
|
2024
Q3 | $4.35M | Buy |
36,542
+213
| +0.6% | +$25.4K | 1.78% | 20 |
|
|
2024
Q2 | $5.19M | Buy |
36,329
+8,777
| +32% | +$1.25M | 2.13% | 15 |
|
|
2024
Q1 | $3.54M | Buy |
27,552
+90
| +0.3% | +$11.6K | 1.46% | 26 |
|
|
2023
Q4 | $2.84M | Buy |
27,462
+32
| +0.1% | +$3.31K | 1.27% | 29 |
|
|
2023
Q3 | $2.49M | Sell |
27,430
-660
| -2% | -$60K | 1.26% | 28 |
|
|
2023
Q2 | $2.27M | Buy |
28,090
+2,716
| +11% | +$220K | 1.03% | 31 |
|
|
2023
Q1 | $2.02M | Buy |
+25,374
| New | +$2.02M | 0.94% | 31 |
|